29th Annual Cardiovascular Interventions 2018

29th Annual Cardiovascular Interventions is organized by Promedica International CME and will be held from Oct 23 - 26, 2018 at Hilton La Jolla Torrey Pines, La Jolla, California, United States of America.

The target audience for this medical event is interventional cardiologists, cardiac surgeons, vascular surgeons, and internists with an interest in interventional cardiology. No experience is in interventional cardiology is required, but a basic understanding of the field is recommended. This CME Conference has been approved for a maximum of 27.6 Category 1 CEUs.

Cardiologists are trained during their fellowship years in the latest techniques, technologies, standards of practice and guidelines for patient care. However, the practice of medicine changes rapidly and the discipline of interventional cardiology changes, dramatically, each year. Changes in interventional cardiology directly impact patient care and require specific changes to physician practice. To stay current, physicians rely on journal articles, interaction with colleagues and isolated lectures throughout the year. The primary purpose of Cardiovascular Interventions is to provide the practicing physician with a concentrated exposure to new developments in interventional cardiology that will positively influence patient outcomes.

Through a program of lectures from world experts, live demonstration procedures and participant-faculty interactions, attendees will learn the latest advances in interventional cardiology. After completing this program, participants will return to their practice environment armed with the latest evidence base and practical information to improve patient outcomes.

Educational Objectives :
After attending this activity, participants should be able to:
• Apply new technical approaches to specific lesion subsets such as bifurcation lesions, left main lesions, chronic total occlusions and saphenous vein graft disease
• Integrate the latest guidelines and practice improvements into the management of myocardial function
• Discuss new techniques under development for percutaneous cardiac valve repair and replacement
• Reduce common catheterization laboratory patient complications using new techniques and technologies
• Critique the latest evidence supporting new cardiac imaging modalities such as IVUS, OCT and FFR guided stent deployment
• Prescribe the appropriate antithrombotic therapies based on the latest data and guidelines

Additional details will be posted as soon as they are available.